Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST-DS
NCT07112365Phase 4Recruiting
- Sponsor
- UTHealth Houston
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenfluramine in Dravet syndrome, sponsored by UTHealth Houston. Started Apr 2026; status: recruiting.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT07112365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112365.